Improving Diabetes Outcomes for Persons With Severe Mental Illness
1 other identifier
interventional
18
1 country
1
Brief Summary
Persons with severe mental illness are at great risk for developing type 2 diabetes (T2DM). Unfortunately, persons with mental illness and T2DM are less likely to receive recommended diabetes monitoring and are more likely to have poorly controlled diabetes, which leads to microvascular and macrovascular complications later in life. Evidence-based diabetes self-management education and support interventions have yet to be adapted for persons with mental illness and there have been no randomized controlled trials (RCTs) to examine their feasibility and efficacy. The purpose of this study is to assess the feasibility of conducting a RCT of a diabetes self-management intervention for persons with severe mental illness and T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started Dec 2013
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 21, 2014
CompletedFirst Posted
Study publicly available on registry
February 4, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2015
CompletedMay 9, 2017
May 1, 2016
1.5 years
January 21, 2014
May 7, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in knowledge of diabetes self-management from baseline to six months as evidenced by scores on the Stanford Diabetes Self-Management Questionnaire.
Baseline, 6 months
Secondary Outcomes (11)
Changes in HBA1c values from baseline to six months.
Baseline, 6 months
Changes in diabetes self-efficacy from baseline to six months as evidenced by scores on the Stanford Diabetes Self-Efficacy Questionnaire.
Baseline, 6 months
Changes in eating self-efficacy from baseline to six months as evidenced by scores on a standardized measure of eating self-efficacy.
Baseline, 6 months
Changes in exercise self-efficacy from baseline to six months as evidenced by scores on a standardized measure of exercise self-efficacy.
Baseline, 6 months
Changes in healthy lifestyle activities from baseline to six months as evidenced by scores on a standardized measure of adult health behavior.
Baseline, 6 months
- +6 more secondary outcomes
Study Arms (1)
Self-management and education group
OTHERSelf-management and education group - 8 weeks of group-based information and activities designed to improve diabetes self-management
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary S Cuddeback, Ph.D.
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2014
First Posted
February 4, 2014
Study Start
December 1, 2013
Primary Completion
June 15, 2015
Study Completion
December 31, 2015
Last Updated
May 9, 2017
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share